Literature DB >> 28756483

Identification of Structure-Stabilizing Interactions in Enzymes: A Novel Mechanism to Impact Enzyme Activity.

Marisol Serrano1, Veronica Gonzalez1, Supriyo Ray1, Maria D Chavez1, Mahesh Narayan2.   

Abstract

Cruzain, a cysteine protease in the cathepsin family, is pivotal to the life-cycle of Trypanosoma cruzi, the etiological agent in Chagas disease. Current inhibitors of cruzain suffer from drawbacks involving gastrointestinal and neurological side effects and as a result have spurred the search for alternative anti-trypanocidals. Through sequence alignment studies and intra-residue interaction analysis of the pro-protein of cruzain (pro-cruzain), we have identified a host of non-active site residues that are conserved among the cathepsins. We hypothesize that these conserved amino acids play a critical role in structure-stabilizing interactions among the cathepsins and are therefore crucial for eventually gaining protease activity. As predicted, mutation of selected conserved non-active site amino-acid candidates in cruzain resulted in a compromised structural stability and a corresponding loss in enzymatic activity relative to wild-type enzyme. By advancing the discovery of novel, non-active-site-based targets to arrest enzymatic activity our results potentially open the field of alternative inhibitor design. The advantages of defining such a non-active-site inhibitor design space is discussed.

Entities:  

Keywords:  Auto-activation; Chagas disease; Circular dichroism; Cysteine protease; Expression; Pro-cruzain; Trypanosoma cruzi

Mesh:

Substances:

Year:  2017        PMID: 28756483      PMCID: PMC7446767          DOI: 10.1007/s12013-017-0816-3

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  24 in total

Review 1.  Processing and activation of lysosomal proteinases.

Authors:  Kazumi Ishidoh; Eiki Kominami
Journal:  Biol Chem       Date:  2002-12       Impact factor: 3.915

2.  Chagas disease in Latin America: an epidemiological update based on 2010 estimates.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-02-06

Review 3.  Cysteine proteases of parasitic organisms.

Authors:  M Sajid; J H McKerrow
Journal:  Mol Biochem Parasitol       Date:  2002-03       Impact factor: 1.759

4.  I-TASSER: a unified platform for automated protein structure and function prediction.

Authors:  Ambrish Roy; Alper Kucukural; Yang Zhang
Journal:  Nat Protoc       Date:  2010-03-25       Impact factor: 13.491

Review 5.  Cysteine protease inhibitors as chemotherapy for parasitic infections.

Authors:  J H McKerrow; J C Engel; C R Caffrey
Journal:  Bioorg Med Chem       Date:  1999-04       Impact factor: 3.641

6.  Folding of subtilisin BPN': role of the pro-sequence.

Authors:  J Eder; M Rheinnecker; A R Fersht
Journal:  J Mol Biol       Date:  1993-09-20       Impact factor: 5.469

7.  Trypanosoma cruzi: isolation and characterization of a proteinase.

Authors:  H A Rangel; P M Araújo; D Repka; M G Costa
Journal:  Exp Parasitol       Date:  1981-10       Impact factor: 2.011

8.  The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.

Authors:  Flavia C G Reis; Tatiana F R Costa; Traian Sulea; Alessandra Mezzetti; Julio Scharfstein; Dieter Brömme; Robert Ménard; Ana Paula C A Lima
Journal:  FEBS J       Date:  2007-03       Impact factor: 5.542

9.  Practical protocols for production of very high yields of recombinant proteins using Escherichia coli.

Authors:  Arun Sivashanmugam; Victoria Murray; Chunxian Cui; Yonghong Zhang; Jianjun Wang; Qianqian Li
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

10.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.